New York State Common Retirement Fund Neu Base Therapeutics, Inc. Transaction History

New York State Common Retirement Fund

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 02, 2021	SELL	$3.27 - $4.76 $418 - $609	-128 Closed	0 $0
Q2 2021 Aug 02, 2021	SELL	$4.63 - $7.34 $42,003 - $66,588	-9,072 Reduced 98.61%	128 $1,000
Q4 2020 Feb 08, 2021	SELL	$6.92 - $9.25 $45,672 - $61,050	-6,600 Reduced 41.77%	9,200 $64,000
Q2 2020 Aug 07, 2020	BUY	$6.69 - $11.51 $105,702 - $181,858	15,800 New	15,800 $139,000

Ticker NBSE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 32,258,700
Description
NeuBase Therapeutics, Inc., a pre-clinical-stage biopharmaceutical company, focuses on the development of therapies to treat rare genetic diseases and cancers caused by mutant genes. The company's proprietary modular peptide-nucleic acid antisense oligo (PATrOL) platform focuses on addressing Huntington's disease (HD) and myotonic dystrophy, as ...

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

Stay updated on New York State Common Retirement Fund with notifications on news.